Serum Institute of India could resume vaccine exports by June if local coronavirus cases subside

Apr 7, 2021 | INVESTING

The world’s largest vaccine maker, based in India, will be able to restart exports of AstraZeneca doses by June if new coronavirus infections subside in the country, its chief executive said on Tuesday.But a continued surge could result in more delays because the Serum Institute of India would have to meet domestic needs, Adar Poonawalla warned. The company is a key supplier for the UN-backed Covax Facility programme that aims to distribute vaccines equitably in the world. On March 25, Covax…

Read More

Pin It on Pinterest